JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.
An article in the March Journal …
Topical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.
An article in the March Journal … Continue reading "JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis"
At the 2026 ODAC Dermatology Conference in Orlando, Florida, Dr. Olayemi Sokumbi, MD delivered a masterclass on clinicopathologic correlation. A board-certified dermatologist and dermatopathologist widely recognized for her expertise in complex medical dermatology, Dr. Sokumbi showcased her special interest in diagnostic dilemmas in her talk. She emphasized the critical role of clinicopathologic c … 
Hair transplantation is becoming a more popular means of addressing hair loss. Social media is fueling the trend with an increase in women, men, and young adults seeking hair transplantation. Among people with afro-textured hair, rising alopecia rates are driving more interest in surgical restoration, though the approach is not without concern. Afro-textured hair tends to grow more slowly compared … 
Clinical case reports are a foundational component of research output for those involved in academic dermatology, be it medical students hoping to match into residency, residents applying to fellowship, trainees looking for their first job, and even junior faculty in tenure-track position. Although they are considered to be bottom tier when it comes to the "levels of evidence" (just above expert o … 
The intermittent nature of chronic spontaneous urticaria (CSU) can lead to diagnostic and treatment delays, especially in patients with skin of color whose skin changes may not be as recognizable. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Mona Shahriari, associate clinical professor of dermatology at Yale University School of Medicine, about the disease that sh …